NCT04530955View on ClinicalTrials.gov

Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS)

NAUnknownINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

September 24, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

June 30, 2023

Conditions
Injuries, Spinal CordCVA (Cerebrovascular Accident)Traumatic Brain InjuryMS (Multiple Sclerosis)Muscle SpasticityCerebral Palsy, Spastic
Interventions
DEVICE

Prometra II Programmable Pump - Flowonix Medical

The valve gated Prometra II Programmable Pump will be replacing the prior peristaltic Synchromed II pump and a 20% dose decrease will be performed at the time of the replacement.

Trial Locations (1)

70072

RECRUITING

Culicchia Neurological Clinic, Marrero

Sponsors

Collaborators (1)

Flowonix Medical
All Listed Sponsors
collaborator

Flowonix Medical

INDUSTRY

lead

Culicchia Neurological Clinic

OTHER

NCT04530955 - Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS) | Biotech Hunter | Biotech Hunter